Vaccinations

Vaccinations

Prevenar 13 (Pneumococcal 13-valent Conjugate Vaccine)

Age Group:
Adult and Children above 4 Months Old
Indications:
Prevenar 13 ®️ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM 197 Protein ]) is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F).
Doses:
Children above 4 months: First Dose – 4 months of age | Second Dose – 6 months of age | Third Dose – 12 months of age
Children aged 12 to 23 months: First Dose – On elected date | Second Dose – 2 months from the first dose
Adults and Children aged 2 to 17 years: One Dose

Boostrix (Tdap vaccine Vaccine)

Age Group:
Adult and Children;10 years and above
Indications:
Boostrix is a vaccine that’s used to help prevent diseases tetanus, diphtheria and pertussis (whooping cough).
Doses:
One Dose after the age of 10 years if child completed childhood vaccination schedule according to NIR

Engerix-B (Adult, Hepatitis B Vaccine)

Age Group:
Adult 20 years and above
Indications:
Engerix B is indicated for immunisation against infection caused by all known subtypes of Hepatitis B virus
Doses:
First Dose – On elected date | Second Dose – 1 month after the first dose. | Third Dose – 6 months after the second dose

Infanrix IPV/Hib (5 in 1, Combined diphtheria-tetanus-acellular pertussis, enhanced inactivated polio and Haemophilus influenzae type b Vaccine)

Age Group:
Infants 2 months and above
Indications:
Infanrix-IPV+Hib is indicated for active immunisation in infants from the age of 2 months against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae Type B.
Infanrix-IPV+Hib is also indicated as a booster dose for children who have previously been immunised with diphtheria, tetanus, pertussis (DTP), polio and Hib antigens.
Doses:
Infants: First Dose – 2 months | Second Dose – 4 months | Third Dose – 6 months 
Children aged 12 to 23 months: One Dose if recommended
Adults and Children aged 2 to 17 years: One Dose if recommended

Infanrix Hexa (6 in 1, Combined diphtheria-tetanus-acellular pertussis, Hepatitis B, enhanced inactivated polio and Haemophilus influenzae type b Vaccine)

Age Group:
Infants 2 months and above
Indications:
Infanrix Hexa is indicated for active immunisation in infants from the age of 2 months against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type b.
Infanrix Hexa is also indicated as a booster dose for children who have previously been immunised with diphtheria, tetanus, pertussis (DTP), hepatitis b, polio and Hib antigens..
Doses:
Infants: First Dose – 2 months | Second Dose – 4 months | Third Dose – 6 months 
Children: One Dose if recommended
Adults: One Dose if recommended

Havrix 1440 (Adult, Hepatitis A Vaccine)

Age Group:
Adults 19 years and above
Indications:
Requires 2 doses, 6 month intervals.
Hepatitis A vaccine (Havrix) is used to prevent hepatitis A, a type of liver disease that is caused by the hepatitis A virus (HAV). Hepatitis A is usually spread when a person ingests fecal matter from contact with food, drinks, or objects which have been contaminated by feces or stool of an HAV-infected person.
Doses: First Dose – On elected date | Second Dose – 6 months from first dose

Havrix 720 (Children, Hepatitis A Vaccine)

Age Group:
12 months to 12 years old
Indications:
Requires 2 doses, 6 month intervals.
Hepatitis A vaccine (Havrix) is used to prevent hepatitis A, a type of liver disease that is caused by the hepatitis A virus (HAV). Hepatitis A is usually spread when a person ingests fecal matter from contact with food, drinks, or objects which have been contaminated by feces or stool of an HAV-infected person.
Doses: First Dose – On elected date | Second Dose – 6 months from first dose

Tetavax (Tetanus Vaccine)

Age Group:
Adults
Indications:
Tetanus prevention and, in particular: Post-exposure tetanus prophylaxis for recent wounds that may have been contaminated with tetanus spores in subjects who have not had any primary vaccination or for whom primary vaccination is incomplete or uncertain; Neonatal tetanus prophylaxis in non-immunised women either of childbearing age or pregnant in countries where neonatal tetanus is frequent; Primary vaccination; Booster injections.
Doses: Anti infectious vaccine indicated in the prevention of tetanus.

Gardasil 9 (Human Papillomavirus 9 – valent Vaccine, Recombinant)

Age Group:
Adult, Children 14 years and above
Indications:
– GARDASIL 9 is a vaccine indicated in females 9 through 45 years of age for the prevention of cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by human papillomavirus (HPV) Types 16, 18, 31, 33, 45, 52, and 58
– GARDASIL 9 is indicated in males 9 through 45 years of age for the prevention of anal, oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, and 58
Doses: First Dose – On elected date | Second Dose – 2 months from first dose | Third Dose – 6 months from the second dose

Zostavax (Shingles Vaccine)

Age Group:
Adults 50 years and above
Indications:
ZOSTAVAX is indicated for prevention of herpes zoster (“zoster” or shingles) and herpes zoster-related post-herpetic neuralgia (PHN) and for reduction of acute and chronic zoster-associated pain.
Doses: One Dose needed

Varivax (Varicella-Zoster Vaccine)

Age Group:
Infants and Children 12 months to 12 years of age
Adolescents and Adults 13 years of age and above
Indications:
VARIVAX is indicated for vaccination against varicella in individuals 12 months of age and older.
Doses:
Children above 12 months:
First Dose – On elected date | Second Dose – 2 months from first dose | Third Dose – 6 months from the second dose
Adolescents and Adults:
First Dose – On elected date | Second Dose – 4 to 8 weeks later

Twinrix (Hepatitis B & A Vaccine)

Age Group:
Adults 18 years and above
Indications:
TWINRIX® 3 is indicated for active immunization against disease caused by hepatitis A virus and 4 infection by all known subtypes of hepatitis B virus.
Doses: First Dose – On elected date | Second Dose – 1 month later from first dose | Third Dose – 6 months later from second dose

MMR II (Measles, Mumps and Rubella Vaccine)

Age Group:
Infants 12 months and above, Children and Adults
Indications:
M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live, MSD) is a live virus vaccine for vaccination against measles (rubeola), mumps and rubella (German measles).
Doses:
Infants: First Dose – 12 months | Second Dose – 15 months
Children: First Dose – On elected date | Second dose – 1 month later
Adults: One Dose. A second dose would be recommended if patient poses a high risk to measles or mumps transmission.

Fluarix Tetra (Flu Vaccine)

Age Group:
Adult and Children above 6 months old
Indications:
FLUARIX TETRA is indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine.
Important to note: The flu vaccine may contain egg protein and is not suitable for individuals who are allergic to it.
Doses:
Infants 6 months to Children less than 9 years: First Dose – On elected date | Second Dose – 1 month after the first dose
Adults: One Dose